Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 2
1987 1
1988 2
1989 1
1990 2
1991 3
1997 4
1998 2
1999 2
2000 4
2001 1
2002 2
2003 1
2004 2
2005 2
2006 3
2007 1
2008 1
2009 1
2013 1
2014 3
2017 1
2018 2
2019 2
2020 2
2021 3
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Molecular MRD status and outcome after transplantation in NPM1-mutated AML.
Dillon R, Hills R, Freeman S, Potter N, Jovanovic J, Ivey A, Kanda AS, Runglall M, Foot N, Valganon M, Khwaja A, Cavenagh J, Smith M, Ommen HB, Overgaard UM, Dennis M, Knapper S, Kaur H, Taussig D, Mehta P, Raj K, Novitzky-Basso I, Nikolousis E, Danby R, Krishnamurthy P, Hill K, Finnegan D, Alimam S, Hurst E, Johnson P, Khan A, Salim R, Craddock C, Spearing R, Gilkes A, Gale R, Burnett A, Russell NH, Grimwade D. Dillon R, et al. Among authors: spearing r. Blood. 2020 Feb 27;135(9):680-688. doi: 10.1182/blood.2019002959. Blood. 2020. PMID: 31932839 Free PMC article. Clinical Trial.
Derek Nigel John Hart (1952-2017).
Spearing R, Bradstock K, Snowden JA. Spearing R, et al. Bone Marrow Transplant. 2019 Feb;54(2):173-174. doi: 10.1038/s41409-018-0295-1. Epub 2018 Aug 14. Bone Marrow Transplant. 2019. PMID: 30108324 No abstract available.
Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria.
Kulasekararaj AG, Lehtinen AE, Forsyth C, Gandhi S, Griffin M, Körper S, Mikala G, Muus P, Overgaard U, Patriquin CJ, Pullon H, Shen YM, Spearing R, Szer J, De la Borderie G, Duda PW, Farzaneh-Far R, Ragunathan S, Sayegh CE, Vadysirisack DD, Schrezenmeier H. Kulasekararaj AG, et al. Among authors: spearing r. Haematologica. 2024 Mar 1;109(3):929-935. doi: 10.3324/haematol.2022.281780. Haematologica. 2024. PMID: 37534517 Free PMC article. Clinical Trial. No abstract available.
Trisomy 10 in acute myeloid leukemia: three new cases.
Llewellyn IE, Morris CM, Stanworth S, Heaton DC, Spearing RL. Llewellyn IE, et al. Among authors: spearing rl. Cancer Genet Cytogenet. 2000 Apr 15;118(2):148-50. doi: 10.1016/s0165-4608(99)00134-x. Cancer Genet Cytogenet. 2000. PMID: 10748296 Review.
WhiMSICAL: A global Waldenström's Macroglobulinemia patient-derived data registry capturing treatment and quality of life outcomes.
Tohidi-Esfahani I, Warden A, Malunis E, DeNardis PL, Haurat J, Black M, Opat S, Kee D, D'Sa S, Kersten MJ, Spearing RL, Palomba ML, Olszewski AJ, Harrington C, Scott CL, Trotman J. Tohidi-Esfahani I, et al. Among authors: spearing rl. Am J Hematol. 2021 Jun 1;96(6):E218-E222. doi: 10.1002/ajh.26173. Epub 2021 Apr 9. Am J Hematol. 2021. PMID: 33755232 Free article. No abstract available.
Māori and Pacific Peoples With Multiple Myeloma in New Zealand are Younger and Have Inferior Survival Compared to Other Ethnicities: A Study From the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
Moore EM, Blacklock H, Wellard C, Spearing R, Merriman L, Poplar S, George A, Baker B, Chan H, McQuilten ZK, Wood EM, Spencer A; MRDR investigators. Moore EM, et al. Among authors: spearing r. Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):e762-e769. doi: 10.1016/j.clml.2022.04.004. Epub 2022 Apr 8. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35501256
Dendritic cells in chronic myelomonocytic leukaemia.
Vuckovic S, Fearnley DB, Gunningham S, Spearing RL, Patton WN, Hart DN. Vuckovic S, et al. Among authors: spearing rl. Br J Haematol. 1999 Jun;105(4):974-85. doi: 10.1046/j.1365-2141.1999.01431.x. Br J Haematol. 1999. PMID: 10554809 Free article.
Receiving four or fewer cycles of therapy predicts poor survival in newly diagnosed transplant-ineligible patients with myeloma who are treated with bortezomib-based induction.
Boyle S, Wellard C, Moore EM, Blacklock H, Harrison SJ, Ho PJ, Hocking J, McQuilten ZK, Quach H, Spearing R, Wood EM, Spencer A, Mollee P; Myeloma and Related Diseases Registry investigators. Boyle S, et al. Among authors: spearing r. Eur J Haematol. 2021 Oct;107(4):497-499. doi: 10.1111/ejh.13677. Epub 2021 Jun 26. Eur J Haematol. 2021. PMID: 34129711 No abstract available.
51 results